Description
rHGH (Recombinant human growth hormone) 12 mg Nouveaux — Recombinant Human Growth Hormone represents the pinnacle of body transformation pharmacology. Unlike anabolic steroids that primarily affect existing muscle cells, HGH promotes actual cellular proliferation (hyperplasia), creates new muscle fibers, and simultaneously mobilizes stored body fat for energy. This formulation is dosed at 12 mg per unit.
Key Benefits
- Recombinant 191-amino-acid sequence — identical to pituitary HGH
- Mobilises visceral fat, improves recovery, thickens connective tissue
- Long-game compound — 3–6 month commitment minimum
- Does not suppress HPTA, does not aromatise
- Cold-chain storage after reconstitution; lyophilised vial stable at 2–8 °C
- Each unit dosed at 12 mg — see Recommended Dosage below for protocol-specific intake
Recommended Dosage
Research dosing: fat-loss / recovery 2–3 IU/day SubQ AM; bodybuilding 4–6 IU/day; anti-aging 1–2 IU/day. Morning dosing on empty stomach maximises lipolytic window. Cycles 3–6 months minimum — effects are cumulative, not acute.
How It Works
Recombinant growth hormone (somatotropin), 191-amino-acid single-chain polypeptide produced via E. coli expression. Binds pituitary-axis-independent GH receptors; liver converts to IGF-1 (primary mediator of growth effects). Drives lipolysis, collagen synthesis, and satellite-cell recruitment.
Pharmacokinetics
HGH plasma half-life ~2–3 hours; IGF-1 signalling downstream persists 12–16 hours — hence once-daily dosing produces clinical effect despite short serum residency. Reconstituted vial stable 2–8 °C for 14 days.
Potential Side Effects
Dose-dependent: 1–3 IU/day well-tolerated; 4 IU+/day water retention, carpal-tunnel symptoms, insulin resistance risk. Fasting glucose monitoring quarterly on extended runs. HbA1c at month 3. Insulin resistance the main long-run concern above 4 IU.
Cycle & Stacking Guide
3–6 month protocols. Stacks cleanly with TRT, blasts, and peptide secretagogues. Target IGF-1 on 2.5 IU/day: 250–350 ng/mL. Pull IGF-1 at week 8 to verify product activity — if still baseline (~150 ng/mL), either dose too low or product underdosed.
Manufacturer Notes
Nouveaux focuses on high-concentration injectable AAS and peptides. Standard batch QC documentation; scannable authenticity verifiers on each vial.
Storage & Handling
Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.
Reviews
There are no reviews yet.